Medinotec Inc. (MDNC) stock

MDNCOTCSurgical & Medical Instruments & ApparatusFiscal year ends February 28

Financials through Q2 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 9/30

$5.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $58.78MP/E –Yield –

Medinotec price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Medinotec's price to sales ratio was 5.8× on Oct 16, 2026, against 5.1× a year earlier. Over the last 3 years it ranged from 0.0× to 11.7×, with a median of 5.9×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 16, 2026	5.8×	+0.6
2025	Dec 31, 2025	5.1×	−2.9
2024	Dec 31, 2024	8.0×	+8.0
2023	Sep 29, 2023	0.0×	–

Where these numbers come from

Parsed from the XBRL in Medinotec's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MDNC.

Compare: MDNC vs NSPR · MDNC vs BDMD · MDNC vs XAIR · MDNC vs WOK · MDNC vs ECIA

Revenue growth-10.9% · median 41.2%

Gross margin49.6% · median 18.1%

Operating margin6.6% · median -321.7%

Net margin5.8% · median -407.3%

Company	Revenue	Growth
NSPR	$10.84M	+53.4%
MDNC	$10.21M	-10.9%
XAIR	$8.19M	+41.2%
ECIA	$6.30M	-3.0%
BDMD	–	–
WOK	–	–

Company

Exchange: OTC
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: February 28
Employees: 48
Auditor: Mercurius & Associates LLP
SEC CIK: 1931055

Advertisement
300 × 250

See a number that looks wrong?

Medinotec price to sales ratio

Price to Sales Ratio at the end of each year

More Medinotec figures